{
    "body": "What was the aim of the HAMLET clinical trial?", 
    "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/17400593", 
        "http://www.ncbi.nlm.nih.gov/pubmed/16965617", 
        "http://www.ncbi.nlm.nih.gov/pubmed/19269254", 
        "http://www.ncbi.nlm.nih.gov/pubmed/23868265", 
        "http://www.ncbi.nlm.nih.gov/pubmed/14723030", 
        "http://www.ncbi.nlm.nih.gov/pubmed/17303527", 
        "http://www.ncbi.nlm.nih.gov/pubmed/23943217"
    ], 
    "ideal_answer": [
        "The aim of the HAMLET (Hemicraniectomy After Middle Cerebral Artery Infarction With Life-Threatening Edema Trial) clinical trial was to compare the efficacy of decompressive surgery to improve functional outcome with that of conservative treatment in patients with space-occupying supratentorial infarction.", 
        "The  Hemicraniectomy after middle cerebral artery infarction with life-threatening edema trial  (HAMLET) is a newly-conceived randomised multi-centre clinical trial that compares the efficacy of decompressive surgery to improve functional outcome with that of conservative treatment in patients with space-occupying supratentorial infarction.  "
    ], 
    "type": "summary", 
    "id": "54d776453706e89528000018", 
    "snippets": [
        {
            "offsetInBeginSection": 212, 
            "offsetInEndSection": 531, 
            "text": "METHODS: We assessed clinical outcomes, costs, and cost-effectiveness for the first 3 years in patients who were randomized to surgical decompression or best medical treatment within 48 hours after symptom onset in the Hemicraniectomy After Middle Cerebral Artery Infarction With Life-Threatening Edema Trial (HAMLET). ", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/23943217", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 115, 
            "text": "Surgical decompression for space-occupying cerebral infarction: outcomes at 3 years in the randomized HAMLET trial.", 
            "beginSection": "title", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/23868265", 
            "endSection": "title"
        }, 
        {
            "offsetInBeginSection": 172, 
            "offsetInEndSection": 413, 
            "text": "METHODS: Patients with space-occupying hemispheric infarction, who were enrolled in the Hemicraniectomy After Middle cerebral artery infarction with Life-threatening Edema Trial within 4 days after stroke onset, were followed up at 3 years. ", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/23868265", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 263, 
            "offsetInEndSection": 622, 
            "text": "We studied differences in recall of information and in appreciation of the informed consent procedure between representatives included in the Hemicraniectomy After Middle cerebral artery infarction with Life-threatening Edema Trial (HAMLET) and representatives of patients participating in the randomised trial of Paracetamol (Acetaminophen) In Stroke (PAIS).", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/17400593", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 99, 
            "text": "Hemicraniectomy after middle cerebral artery infarction with life-threatening Edema trial (HAMLET).", 
            "beginSection": "title", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/16965617", 
            "endSection": "title"
        }, 
        {
            "offsetInBeginSection": 381, 
            "offsetInEndSection": 577, 
            "text": "This study is designed to compare the efficacy of decompressive surgery to improve functional outcome with that of conservative treatment in patients with space-occupying supratentorial infarction", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/16965617", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 375, 
            "offsetInEndSection": 717, 
            "text": "The 'Hemicraniectomy after middle cerebral artery infarction with life-threatening edema trial' (HAMLET) is a newly-conceived randomised multi-centre clinical trial that compares the efficacy of decompressive surgery to improve functional outcome with that of conservative treatment in patients with space-occupying supratentorial infarction.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/14723030", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 331, 
            "offsetInEndSection": 494, 
            "text": "The aim of HAMLET was to assess the effect of decompressive surgery within 4 days of the onset of symptoms in patients with space-occupying hemispheric infarction.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/19269254", 
            "endSection": "abstract"
        }
    ]
}